New Zealand markets close in 5 minutes

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
63.47-1.12 (-1.73%)
At close: 04:00PM EST
64.50 +1.03 (+1.62%)
After hours: 07:59PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
645,564
540,099
380,833
301,034
Cost of revenue
87,709
63,382
56,586
34,193
Gross profit
557,855
476,717
324,247
266,841
Operating expenses
Research development
781,125
722,343
560,909
401,843
Selling general and administrative
290,651
317,875
284,812
209,983
Total operating expenses
1,072,468
1,040,880
846,570
612,691
Operating income or loss
-514,613
-564,163
-522,323
-345,850
Interest expense
66,207
59,947
30,669
33,709
Total other income/expenses net
94,946
68,075
-168,126
10,139
Income before tax
-485,544
-553,065
-713,880
-362,610
Income tax expense
572
1,063
1,195
-692
Income from continuing operations
-486,116
-554,128
-715,075
-361,918
Net income
-486,116
-554,128
-715,075
-361,918
Net income available to common shareholders
-486,116
-554,128
-715,075
-361,918
Basic EPS
-
-7.11
-9.71
-5.46
Diluted EPS
-
-7.11
-9.71
-5.46
Basic average shares
-
77,956
73,615
66,250
Diluted average shares
-
77,956
73,615
66,250
EBITDA
-
-466,207
-652,664
-316,656